Dr. Zijun Zhen 甄子俊
Chief Physician
Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of malignant tumors in children and adolescents under 18, with a focus on lymphoma and solid tumors including medulloblastoma, hepatoblastoma, neuroblastoma, Wilms tumor, Ewing sarcoma, rhabdomyosarcoma, osteosarcoma, and germ cell tumors.
Dr. Zhen is a Chief Physician and Professor at Sun Yat-sen University Cancer Center. Dr. Zhen holds an MD and PhD from Sun Yat-sen University. Training includes pediatric clinical work in Guangdong and visiting scholar positions at Queen Mary Hospital (2016) and Children’s Hospital Los Angeles (2016–2017). Dr. Zhen served in the Chinese medical aid team to Dominica (2019–2020).
Professional roles
- Vice Chair and Secretary-General, Pediatric Oncology Professional Committee, Guangdong Anti-Cancer Association
- Vice Chair, Pediatric Hematology-Oncology Professional Committee, Guangdong Clinical Medical Association
- Member, Pediatric Oncology Professional Committee, China Anti-Cancer Association
- Member, Oncology Group, Pediatrics Branch, Chinese Medical Association
Name order: in Chinese the family name comes first (Zhen Zijun). Papers usually list the name as Zijun Zhen or Zhen Z.
Selected publications
77 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2026 (senior author): Mechanism by which SAHA regulates HLA-E expression via the endoplasmic reticulum stress-related PERK/ATF4/CHOP pathway in neuroblastoma. PubMed 41958679
- Chin Clin Oncol, 2026 (senior author): Causal relationship between renin-angiotensin system inhibitors and cancer: a two-sample, two-step Mendelian randomization study. PubMed 41797472
- Transl Cancer Res, 2025 (senior author): Causal relationship between hypertension and cancer: a two‑sample bidirectional Mendelian randomization study. PubMed 41378016
- BMC Cancer, 2025 (senior author): Prognostic implication of serum levels of IL-6 and IL-10 in children and adolescents with aggressive mature B-cell non-Hodgkin lymphoma. PubMed 41299342
- Pediatr Blood Cancer, 2025 (senior author): Prognostic Value of Peripheral Blood Lymphocyte Subsets in Children and Adolescents With High-Grade Mature B-Cell Non-Hodgkin Lymphoma: A Real-World Outcomes Study. PubMed 39976421
- Cancer, 2024 (senior author): Effect of body mass index on the prognosis of children and adolescents with high-grade mature B-cell non-Hodgkin lymphoma. PubMed 39174494
- Cancer Rep (Hoboken), 2024 (senior author): Mechanism of Drug Resistance to First-Line Chemotherapeutics Mediated by TXNDC17 in Neuroblastomas. PubMed 39411839
- Cancer Res Treat, 2024 (senior author): Stratified Treatment in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study. PubMed 38810968
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion